StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.86+0.31 (+2.29%)

Close on Nov 18, 2026Market cap $1.08BP/E 81.5Yield –

Integra LifeSciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Integra LifeSciences's operating cash flow for the twelve months ending Sep 30, 2026 was $140.40M, up 57.2% year over year. For fiscal 2025 it was $50.38M, down 61.1% from the year before. Over ten years it grew -7.1% a year on average. The highest annual figure on record is $312.43M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$50.38M-61.1%
FY2024Dec 31, 2024$129.38M-7.6%
FY2023Dec 31, 2023$139.96M-47.1%
FY2022Dec 31, 2022$264.47M-15.4%
FY2021Dec 31, 2021$312.43M+53.3%
FY2020Dec 31, 2020$203.83M-11.9%
FY2019Dec 31, 2019$231.43M+15.9%
FY2018Dec 31, 2018$199.68M+74.3%
FY2017Dec 31, 2017$114.54M-1.6%
FY2016Dec 31, 2016$116.41M+11.0%
FY2015Dec 31, 2015$104.85M+25.5%
FY2014Dec 31, 2014$83.57M+56.9%
FY2013Dec 31, 2013$53.27M-9.9%
FY2012Dec 31, 2012$59.10M-43.4%
FY2011Dec 31, 2011$104.33M-1.2%
FY2010Dec 31, 2010$105.57M-26.3%
FY2009Dec 31, 2009$143.24M+97.3%
FY2008Dec 31, 2008$72.59M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$95.98M+134.6%
Q2 FY2026Jun 30, 2026$22.80M+155.7%
Q1 FY2026Mar 31, 2026$9.80M–
Q4 FY2025Dec 31, 2025$11.82M-76.7%
Q3 FY2025Sep 30, 2025$40.91M+81.9%
Q2 FY2025Jun 30, 2025$8.92M-77.9%
Q1 FY2025Mar 31, 2025-$11.26M-171.4%
Q4 FY2024Dec 31, 2024$50.74M-13.6%
Q3 FY2024Sep 30, 2024$22.49M-16.0%
Q2 FY2024Jun 30, 2024$40.40M+42.9%
Q1 FY2024Mar 31, 2024$15.76M-39.8%
Q4 FY2023Dec 31, 2023$58.75M-31.2%
Q3 FY2023Sep 30, 2023$26.77M-60.8%
Q2 FY2023Jun 30, 2023$28.28M-57.5%
Q1 FY2023Mar 31, 2023$26.16M-41.0%
Q4 FY2022Dec 31, 2022$85.33M+23.2%
Q3 FY2022Sep 30, 2022$68.31M-17.5%
Q2 FY2022Jun 30, 2022$66.48M-27.2%
Q1 FY2022Mar 31, 2022$44.34M-35.8%
Q4 FY2021Dec 31, 2021$69.28M-13.7%
Q3 FY2021Sep 30, 2021$82.78M+18.9%
Q2 FY2021Jun 30, 2021$91.29M+175.7%
Q1 FY2021Mar 31, 2021$69.08M+231.9%
Q4 FY2020Dec 31, 2020$80.26M-10.0%
Q3 FY2020Sep 30, 2020$69.64M+8.4%
Q2 FY2020Jun 30, 2020$33.12M-31.8%
Q1 FY2020Mar 31, 2020$20.81M-29.4%
Q4 FY2019Dec 31, 2019$89.18M+108.9%
Q3 FY2019Sep 30, 2019$64.24M-18.9%
Q2 FY2019Jun 30, 2019$48.52M+34.0%
Q1 FY2019Mar 31, 2019$29.48M-29.0%
Q4 FY2018Dec 31, 2018$42.69M+269.6%
Q3 FY2018Sep 30, 2018$79.25M+75.2%
Q2 FY2018Jun 30, 2018$36.21M+25.4%
Q1 FY2018Mar 31, 2018$41.53M+43.8%
Q4 FY2017Dec 31, 2017$11.55M+76.9%
Q3 FY2017Sep 30, 2017$45.24M–
Q2 FY2017Jun 30, 2017$28.87M–
Q1 FY2017Mar 31, 2017$28.88M–
Q4 FY2016Dec 31, 2016$6.53M–

More Integra LifeSciences figures

See a number that looks wrong?